Verici Dx PLC to launch TranscripTx™ genetic test in Q4 2026

Verici Dx Plc will launch TranscripTx™, a genetic test designed for the transplant community, in the fourth quarter of 2026. The test uses next-generation sequencing to measure genetic variants found in peripheral blood RNA.